Anthony Japour Net Worth

The estimated Net Worth of Anthony J Japour is at least $1.61 Thousand dollars as of 12 March 2020. Anthony Japour owns over 500 units of Cocrystal Pharma Inc stock worth over $1,610 and over the last 5 years he sold COCP stock worth over $0. In addition, he makes $0 as Independent Director at Cocrystal Pharma Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Anthony Japour COCP stock SEC Form 4 insiders trading

Anthony has made over 2 trades of the Cocrystal Pharma Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 500 units of COCP stock worth $755 on 12 March 2020.

The largest trade he's ever made was buying 500 units of Cocrystal Pharma Inc stock on 12 March 2020 worth over $755. On average, Anthony trades about 143 units every 1 days since 2020. As of 12 March 2020 he still owns at least 1,000 units of Cocrystal Pharma Inc stock.

You can see the complete history of Anthony Japour stock trades at the bottom of the page.

Anthony Japour biography

Dr. Anthony J. Japour M.D. serves as Independent Director of the Company. Dr. Japour was a medical director at ICON Plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. Additionally, since November 2006, Dr. Japour has been the principal of Anthony Japour & Associates, Medical and Scientific Consulting, Inc., a consulting company. From April 2012 until February 2016, Dr. Japour was a medical physician at the Elite Health Medical Group and South Florida Cardiology Associates P.A. Since January 6, 2020, Dr. Japour has served as a director of OPKO and also serves on the Audit Committee. Dr. Japour was designated by Dr. Raymond Schinazi, our principal shareholder, pursuant to the Stockholder Rights Agreement, dated November 24, 2014. Dr. Japour’s qualifications to serve on our Board of Directors include his over 25 years of experience in the pharmaceutical and biotechnology businesses. Additionally, Dr. Japour has extensive experience in the clinical trial process.

How old is Anthony Japour?

Anthony Japour is 60, he's been the Independent Director of Cocrystal Pharma Inc since 2019. There are 5 older and 4 younger executives at Cocrystal Pharma Inc. The oldest executive at Cocrystal Pharma Inc is Phillip Frost, 83, who is the Independent Director.

What's Anthony Japour's mailing address?

Anthony's mailing address filed with the SEC is 4400, Biscayne Boulevard, Little Haiti, Miami, Miami-Dade County, Florida, 33137, United States.

Insiders trading at Cocrystal Pharma Inc

Over the last 10 years, insiders at Cocrystal Pharma Inc have traded over $2,664,250 worth of Cocrystal Pharma Inc stock and bought 23,366,560 units worth $16,815,201 . The most active insiders traders include Phillip Md Et Al Frost Gamm..., Phillip Md Et Al Frost, and Jane Ph D Hsiao. On average, Cocrystal Pharma Inc executives and independent directors trade stock every 113 days with the average trade being worth of $1,616,422. The most recent stock trade was executed by Phillip Md Et Al Frost Gamm... on 4 April 2023, trading 1,015,229 units of COCP stock currently worth $2,000,001.

What does Cocrystal Pharma Inc do?

cocrystal (otcqb:cocp) is a pharmaceutical company seeking to discover novel antiviral therapeutics as treatments for serious and/or chronic viral diseases. cocrystal employs unique technologies and nobel prize winning expertise to create first- and best-in-class antiviral drugs. these technologies, including our nucleoside chemistry expertise and market-focused approach to drug discovery are designed to efficiently deliver small molecule therapeutics that are safe, effective and convenient to administer. the company has identified promising, preclinical stage antiviral compounds for the unmet medical needs including hepatitis, influenza and norovirus infections. cocrystal has previously received strategic investments from teva pharmaceuticals, opko health (opk), dr. raymond schinazi, brace pharmaceutical, llc, and the frost group.

Complete history of Anthony Japour stock trades at Opko Health Inc and Cocrystal Pharma Inc

Cocrystal Pharma Inc executives and stock owners

Cocrystal Pharma Inc executives and other stock owners filed with the SEC include:

• James J. Martin CPA, CPA, M.B.A., MBA,
  Interim Co-CEO, CFO & Corp. Sec.
• Dr. Sam Lee,
  Co-Founder & Pres
• Sam Lee,
  President
• James J. Martin CPA, M.B.A., CPA, MBA,
  CFO & Corp. Sec.
• James Martin,
  Chief Financial Officer
• Gary Wilcox,
  Chairman of the Board, Chief Executive Officer
• Dr. Roger D. Kornberg Ph.D.,
  Co-Founder, Chairman & Scientific Advisory Board and Chief Scientist
• Jenene Thomas,
  IR Contact Officer
• Steven Rubin,
  Independent Director
• Anthony Japour,
  Independent Director
• Phillip Frost,
  Independent Director
• Roger Kornberg,
  Director
• Richard C Jr Pfenniger,
  Director
• Jane Ph D Hsiao,
  
• David S Block,
  
• Gerald A Mc Guire,
  CHIEF FINANCIAL OFFICER
• Jeffrey A Meckler,
  
• Douglas L Mayers,
  CHIEF MEDICAL OFFICER
• Curtis Dale,
  INTERIM CFO
• Walt Addison Linscott,
  GENERAL COUNSEL AND SECRETARY
• Raymond F Schinazi,
  10% owner
• Phillip Md Et Al Frost,
  Director
• Fred Hassan,
  Director